Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Condensed Consolidated Statements of Operations [Abstract]        
Revenue $ 114,568 $ 260,845 $ 216,393 $ 359,974
Cost of Revenue 59,731 205,673 114,512 269,772
Gross Profit 54,837 55,172 101,881 90,202
Operating Expenses:        
Selling expenses 8,524 39,485 13,747 75,405
Administrative expenses 172,814 138,416 1,452,018 355,406
Research and development    60,841 3,020 118,117
Depreciation 794 2,402 2,342 4,890
Total Operating Expenses 182,132 241,144 1,471,127 553,818
(Loss) from operations (127,295) (185,972) (1,369,246) (463,616)
Other Income (Expenses)        
Gain on derivative financial instrument 122,909 16,520 18,055 23,052
Gain on debt conversion, net 105,081    472,127   
(Loss) share exchange (348,644)    (1,268,286)   
Interest and other expense (46,373) (46,989) (104,820) (85,604)
Total Other Expenses (167,027) (30,469) (882,924) (62,552)
Net loss $ (294,322) $ (216,441) $ (2,252,170) $ (526,168)
(Loss) per share - basic and diluted $ (0.00021) $ (4.464) $ (0.003) $ (11.237)
Weighted Average Number of Shares Outstanding - basic and diluted 1,370,836,289 48,490 678,511,862 46,823